DoriNano, Inc.

DoriNano has developed a method to precisely space multiple different biological payloads at the nanoscale on a delivery vehicle (DNA Origami). Preclinical evidence from the DoriNano team demonstrates that nanoscale difference in the spacing of payloads impacts receptor binding affinity and downstream activity, leading

DoriNano, Inc. operates in cancer.

Profile

DoriNano has developed a method to precisely space multiple different biological payloads at the nanoscale on a delivery vehicle (DNA Origami). Preclinical evidence from the DoriNano team demonstrates that nanoscale difference in the spacing of payloads impacts receptor binding affinity and downstream activity, leading to enhanced immune responses while reducing required dosages by 10-100 fold […]

DoriNano, Inc. is positioned in cancer, a segment that rewards a clear, focused offering.

Its current recorded stage is Creative Destruction Lab alumni company.

Website: www.dorinano.com